Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Cancer Treatment and Pharmacology

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the chemotherapy-induced peripheral neuropathy (CIPN) experienced by cancer patients, particularly in the context of breast cancer treatment. It covers various aspects such as the neurotoxic effects of taxanes and oxaliplatin, neuroprotective strategies, and the impact of CIPN on the quality of life of patients. Additionally, it discusses the use of microtubule-targeting agents like Eribulin Mesylate in cancer treatment.

302
Works

How has Cancer Treatment and Pharmacology's publication output changed over time?

ScholarIQpublication output · 1995–2020

Output grew200% over the shown period — from 1 works in 1995 to 3 in 2020.

1
1
1
2
1
2
1
1
1
3
1995199920042005200720082011201320142020

What are the most-cited papers on Cancer Treatment and Pharmacology?

ScholarIQmost cited works
A simple method for clinical assay of superoxide dismutase.
Yi Sun, L. W. Oberley, Yi Li
S139212996. 19884,485 Citations
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Kathy D. Miller, Molin Wang, Julie R. Gralow, Maura N. Dickler, Melody Cobleigh, Edith A. Perez, Tamara Shenkier, David Cella, Nancy E. Davidson
New England Journal of Medicine. 20073,066 CitationsOPEN ACCESS
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
William J. Gradishar, Sergei Tjulandin, Neville Davidson, Heather Shaw, Neil Desai, Paul Bhar, Michael Hawkins, Joyce O’Shaughnessy
Journal of Clinical Oncology. 20052,143 CitationsOPEN ACCESS
A History of Cancer Chemotherapy
Vincent T. DeVita, Edward Chu
Cancer Research. 20081,955 CitationsOPEN ACCESS
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Doreen M. Agnese, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau T. Dang, Anthony Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Jairam Krishnamurthy, Janice A. Lyons, P. Kelly Marcom, Jennifer M. Matro, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar
Journal of the National Comprehensive Cancer Network. 20201,624 CitationsOPEN ACCESS

Where is Cancer Treatment and Pharmacology research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Cancer Treatment and Pharmacology is open access?

ScholarIQopen access share
47%OPEN ACCESS
Gold
7%
Green
7%
Hybrid
0%
Bronze
33%
Closed
53%

Related on ScholarIQ

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Paper
A simple method for clinical assay of superoxide dismutase.
Paper
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Paper
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Paper
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Paper
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Paper
470M+ articles · free account